Delivery Order SPE2DR25D3112-SPE2DR26FU8VB
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,754.83 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 8mg in a quantity of 30 tablets, with a ceiling value of $6,070.84 and a firm fixed price structure. The delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $9,977.26 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) with an ultimate completion date of December 24, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Ondansetron is a widely used anti-nausea medication commonly...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,087.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 21, 2026, with completion expected by January 22, 2026. This contract was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the parent organization Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,716.88 and an ultimate completion date of August 7, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an...
- The Defense Logistics Agency awarded a delivery order valued at $8,775.67 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is to be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order falls under AmerisourceBergen Drug Corp's parent...
- SPE2DR25D3112Indefinite Delivery Contract
- SPE2DR25D3112-SPE2DR26FU8VBDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 22, 2026, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $9,767.95. This is a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Ondansetron is an anti-nausea medication commonly used in military medical settings and veteran healthcare systems to manage nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery. As a major pharmaceutical distributor, Amerisourcebergen's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical supply needs across multiple therapeutic domains, including specialty medications, generic drugs, and medical devices. The competitively awarded nature of this delivery order, along with the company's substantial IDC with the Defense Logistics Agency, reflects Amerisourcebergen's established position as a critical vendor supporting military healthcare operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 1/21/26 |